Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity
Clinical Chemistry · 2024
DOI: 10.1093/clinchem/hvae102 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Lucille De Maria und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry, Timone University Hospital, AP-HM, Marseille, France. Hauptthemen laut MEDLINE: Chlorides, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Neonatal Screening. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry, Timone University Hospital, AP-HM, Marseille, France.
- Centre for Nutrition and Cardiovascular Disease (C2VN), INSERM, INRAE, Aix Marseille University, Marseille, France.
- Pediatric Pulmonology Department, Timone University Hospital, Marseille, France.
ORCID-Profile: Marion Marlinge, Jean-Christophe Dubus, Julien Fromonot
Zitieren
APA
De Maria, L., Marlinge, M., Baravalle, M., Dubus, J. C., & Fromonot, J. (2024). Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae102
Vancouver
De Maria L, Marlinge M, Baravalle M, Dubus JC, Fromonot J. Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae102
BibTeX
@article{DeMaria2024,
author = {De Maria, Lucille and Marlinge, Marion and Baravalle, Melisande and Dubus, Jean-Christophe and Fromonot, Julien},
title = {Negative Sweat Chloride Testing in the Setting of a Positive Newborn Screen and CFTR Compound Heterozygosity},
journal = {Clinical Chemistry},
year = {2024},
doi = {10.1093/clinchem/hvae102}
}
EUVIMED